In both laboratory and animal studies, it has been demonstrated that MALAT1 is notably increased in CRC and is linked to more advanced TNM staging, lymph node metastasis, and a worse prognosis for patients. This evidence concerns the gene MALAT1 and metastatic malignant neoplasm in the lymph nodes.